{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:17:06Z","timestamp":1774934226829,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002966","name":"Sivas Cumhuriyet University","doi-asserted-by":"publisher","award":["T-2022-945"],"award-info":[{"award-number":["T-2022-945"]}],"id":[{"id":"10.13039\/501100002966","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002966","name":"Sivas Cumhuriyet University","doi-asserted-by":"publisher","award":["ECZ2024-098"],"award-info":[{"award-number":["ECZ2024-098"]}],"id":[{"id":"10.13039\/501100002966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ejogrb.2025.114044","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T19:06:15Z","timestamp":1747163175000},"page":"114044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["IL-8 and ER-\u03b1 gene polymorphisms as potential risk factors for leiomyoma"],"prefix":"10.1016","volume":"311","author":[{"given":"Muazzez","family":"Isik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6397-1291","authenticated-orcid":false,"given":"Ceylan","family":"Hepokur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8374-7892","authenticated-orcid":false,"given":"Arma\u011fan","family":"Akkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-6091","authenticated-orcid":false,"given":"\u015eeyda","family":"Akin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2615-0202","authenticated-orcid":false,"given":"\u0130lhan","family":"Yaylim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5919-3295","authenticated-orcid":false,"given":"Sema","family":"Misir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9482-0231","authenticated-orcid":false,"given":"\u00c7a\u011flar","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2025.114044_b0005","doi-asserted-by":"crossref","unstructured":"Marsh EE, Ekpo GE, Cardozo ER, Brocks M, Dune T, Cohen LS. Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18-30 years old): a pilot study. Fertil Steril [Internet]. 2013 Jun;99(7):1951\u20137. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23498888.","DOI":"10.1016\/j.fertnstert.2013.02.017"},{"key":"10.1016\/j.ejogrb.2025.114044_b0010","unstructured":"Stewart EA, Laughlin-Tommaso SK, Uterine fibroids (leiomyomas): Epidemiology, clinical features, diagnosis, and natural history,2025, www.uptodate.com."},{"issue":"10","key":"10.1016\/j.ejogrb.2025.114044_b0015","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart","year":"2017","journal-title":"BJOG [Internet]"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114044_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ijgo.13102","article-title":"Epidemiology and management of uterine fibroids","volume":"149","author":"Giuliani","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"10.1016\/j.ejogrb.2025.114044_b0025","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1289\/ehp.5787","article-title":"Etiology and pathogenesis of uterine leiomyomas: a review","volume":"111","author":"Flake","year":"2003","journal-title":"Environ Health Perspect"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114044_b0030","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejogrb.2010.05.012","article-title":"The burden of uterine fibroids in five European countries","volume":"152","author":"Downes","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol [Internet]"},{"issue":"24","key":"10.1016\/j.ejogrb.2025.114044_b0035","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.1158\/0008-5472.CAN-17-1744","article-title":"SubtypeSpecific tumor-associated fibroblasts contribute to the pathogenesis of uterine leiomyoma","volume":"77","author":"Wu","year":"2017","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.114044_b0040","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1002\/ctm2.475","article-title":"Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids","volume":"11","author":"Islam","year":"2021","journal-title":"Clin Transl Med"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.114044_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064973","article-title":"The miR-184 binding-site rs8126 T>C polymorphism in TNFAIP2 is associated with risk of gastric cancer","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.ejogrb.2025.114044_b0050","article-title":"A functional TNFAIP2 3'-UTR rs8126 genetic polymorphism contributes to risk of esophageal squamous cell carcinoma","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2025.114044_b0055","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.3389\/fonc.2020.01127","article-title":"Correlation between TNFAIP2 gene polymorphism and prediction\/prognosis for gastric cancer and its effect on TNFAIP2 protein expression","volume":"10","author":"Guo","year":"2020","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.ejogrb.2025.114044_b0060","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/carcin\/bgr209","article-title":"A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck","volume":"32","author":"Liu","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejogrb.2025.114044_b0065","article-title":"Interleukin-8: A chemokine at the intersection of cancer plasticity, angiogenesis, and immune suppression","volume":"219","author":"Fousek","year":"2021","journal-title":"Pharmacol Ther [Internet]"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114044_b0070","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/dna.2020.6089","article-title":"Evaluation ofICAM-1rs5498 and rs3093030 Polymorphisms in chinese patients with colorectal cancer","volume":"40","author":"Qiu","year":"2021","journal-title":"DNA Cell Biol"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.114044_b0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/biomedicines12020321","article-title":"Association of four interleukin-8 polymorphisms (-251 A>T, +781 C>T, +1633 C>T, +2767 A>T) with ovarian cancer risk: Focus on menopausal status and endometriosis-related subtypes","volume":"12","author":"Watrowski","year":"2024","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.ejogrb.2025.114044_b0080","first-page":"22393","article-title":"Association between Interleukin-8-251A\/T polymorphism and gastric cancer susceptibility: a meta-analysis based on 5286 cases and 8000 controls","volume":"8","author":"Zhang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.ejogrb.2025.114044_b0085","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.2147\/OTT.S103159","article-title":"Association of polymorphisms in interleukin-8 gene with cancer risk: a meta-analysis of 22 case-control studies","volume":"9","author":"Zhang","year":"2016","journal-title":"OncoTargets and therapy"},{"issue":"4296","key":"10.1016\/j.ejogrb.2025.114044_b0090","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.325648","article-title":"Rat insulin genes: construction of plasmids containing the coding sequences","volume":"196","author":"Ullrich","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ejogrb.2025.114044_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3825525","article-title":"Relevance of interleukins 6 and 8 single nucleotide polymorphisms in prostate cancer: A multicenter study","volume":"2021","author":"Ghazy","year":"2021","journal-title":"Prostate Cancer"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.114044_b0100","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/nar\/gkl185","article-title":"Algorithm for automatic genotype calling of single nucleotide polymorphisms using the full course of TaqMan real-time data","volume":"34","author":"Callegaro","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114044_b0105","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1067\/mob.2001.111160","article-title":"Interleukin 8 production and interleukin 8 receptor expression in human myometrium and leiomyoma","volume":"184","author":"Senturk","year":"2001","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.114044_b0110","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.fertnstert.2006.07.1541","article-title":"Interleukin (IL)-12 receptor \u03b21 codon 378 G homozygote and allele, but not IL-1 (\u03b2-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3\u2032-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma","volume":"87","author":"Hsieh","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2025.114044_b0115","doi-asserted-by":"crossref","unstructured":"Konenkov VI, Koroleva EG, Orlov NB, Prokof\u2019ev VF, Shevchenko A V., Novikov AM, et al. Blood Serum Levels of Proinflammatory Cytokines (IL1\u03b2, IL-6, TNF\u03b1, IL-8, IL-12p70, and IFN\u03b3) in Patients with Uterine Myoma. Bull Exp Biol Med. 2018 Sep 17;165(5):698\u2013701.","DOI":"10.1007\/s10517-018-4245-0"},{"key":"10.1016\/j.ejogrb.2025.114044_b0120","doi-asserted-by":"crossref","unstructured":"Kitawaki J, Obayashi H, Ishihara H, Koshiba H, Kusuki I, Kado N, Tsukamoto K, Hasegawa G, Nakamura N, Honjo H, Oestrogen receptor-\u03b1 gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. 2001;16(1):51\u20135. doi: 10.1093\/humrep\/16.1.51.","DOI":"10.1093\/humrep\/16.1.51"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114044_b0125","first-page":"BR25","article-title":"Analysis of estrogen receptor (ERalpha and ERbeta) and progesterone receptor (PR) polymorphisms in uterine leiomyomas","volume":"9","author":"Massart","year":"2003","journal-title":"Med Sci Monit [Internet]"},{"key":"10.1016\/j.ejogrb.2025.114044_b0130","unstructured":"F. Massart LBFMINLPFDM et al. Analysis of estrogen receptor (ER\u03b1 and ER\u03b2) and progesterone receptor (PR) polymorphisms in uterine leiomyomas. 2003."},{"issue":"11\u201312","key":"10.1016\/j.ejogrb.2025.114044_b0135","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.steroids.2006.07.005","article-title":"Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma","volume":"71","author":"Villanova","year":"2006","journal-title":"Steroids"},{"issue":"11\u201312","key":"10.1016\/j.ejogrb.2025.114044_b0140","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.cca.2012.01.040","article-title":"Changes in insulin sensitivity during GnRH agonist treatment in premenopausal women with leiomyoma","volume":"413","author":"Matsui","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ejogrb.2025.114044_b0145","first-page":"12","article-title":"Roles of intercellular cell adhesion molecule-1 (ICAM-1) in colorectal cancer: expression, functions, prognosis, tumorigenesis, polymorphisms and therapeutic implications","volume":"23","author":"Qiu","year":"2022","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.114044_b0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.gene.2013.07.049","article-title":"Prediction value of intercellular adhesion molecule-1 gene polymorphisms for epithelial ovarian cancer risk, clinical features, and prognosis","volume":"546","author":"Cai","year":"2014","journal-title":"Gene"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525003203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525003203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:44:11Z","timestamp":1774928651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525003203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":30,"alternative-id":["S0301211525003203"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114044","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-8 and ER-\u03b1 gene polymorphisms as potential risk factors for leiomyoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.114044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114044"}}